FM3 Research Vice President Miranda Everitt has focused on her research on drug policy reform, conservation, and climate policy. Her work has contributed to the passage of state and local ballot measures in Arizona, California, Colorado, Florida, Maine, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, New Jersey, New York, Oregon, South Dakota, Texas, Utah, Washington and Washington, D.C. Miranda also has experience in municipal finance research for scores of cities, counties and school and special districts throughout the country.
Miranda’s research contributed to historic victories for drug policy reform across in the country in November 2020. Voters legalized marijuana for adult use in traditionally conservative states including Montana and South Dakota and approved medical marijuana in Mississippi. In Oregon, she worked to help develop Measure 109, which will allow promising psilocybin therapy to treat depression, end-of-life anxiety, and PTSD. Measure 110, which will decriminalize personal use possession of all drugs, redirecting resources to public health and treatment. Initiative 81 will make entheogens Washington, D.C.’s lowest law-enforcement priority. Since 2015, she has contributed research on campaigns to allow medical or recreational marijuana in a dozen states and helped local governments approach taxation and regulation of this new industry; her work continues to inform legislative and ballot-measure drug reform campaigns in other states.
Miranda came to FM3 with experience in communications and policy research at California Budget and Policy Center, SEIU Healthcare MN, Chief Justice Earl Warren Institute for Law and Social Policy, Justice in Aging, and the Alameda County Community Food Bank. Prior to her policy career, she worked for the Oakland Tribune, San Jose Mercury News and Toledo Free Press.
Miranda holds a Master’s of Public Policy from the Goldman School of Public Policy at UC Berkeley and a journalism degree from Bowling Green State University in Ohio.